Review Papers Claim by Claim

Evidence synthesis — What the data actually show (with direct linking to the preprint)

• Protein structure & domain architecture: Both Aa- and Ch-NF-κB proteins lack the C-terminal ankyrin inhibitory repeats typical of mammalian p100/p105 family and are ~435–477 aa containing mainly the RHD; full sequences and domain maps are provided in the paper and supplemental figures (Preprint: domain architecture).
• DNA binding: Extracts from HEK293T expressing Aa- or Ch-NF-κB bound a mammalian consensus κB oligonucleotide strongly; the ELISA-based assay reported ~>1000-fold signal over empty vector and specific competition by WT but not mutant oligo (authors' values shown in Plot 1) (Preprint: DNA-binding assay).
• Transcriptional activation (heterologous assays): In HEK293 κB-luciferase reporter assays, Nv-NF-κB (sea anemone control) activated ~10×, but Aa- and Ch-NF-κB did not activate the reporter under the same conditions; in yeast GAL4-fusion assays Aa-NF-κB gave ~40× activation while Ch-NF-κB did not activate (Nv control ~100×) — indicates DNA binding alone is insufficient for activation in HEK cells and suggests co-factor/post-translational requirements or inhibitory context differences (Preprint: reporter assays).
• Subcellular localization and regulation: When expressed in DF-1 (chicken fibroblasts), both Aa- and Ch-NF-κB were primarily nuclear (>70–87% cells); jellyfish IκB-like proteins bound their cognate NF-κBs (co-IP) and could relocalize NF-κB to cytoplasm, supported by AlphaFold-predicted docking of ANK repeats to the RHD consistent with mammalian IκB-NFκB interactions (Preprint: localization and IκB interactions).
• Developmental expression (Clytia): Bulk RNA-seq and single-cell atlas indicate high NF-κB and BCL3 mRNA in early stages (gastrula/planula) when IκB mRNA is low, and higher IκB in adult medusa/gonads — authors argue this pattern is consistent with active NF-κB during early development and regulated activation in adults (Preprint: RNA-seq expression patterns).

Critical appraisal — strengths

1. Clear, multi-modal approach combining phylogenetics, biochemical DNA-binding, reporter assays (two heterologous systems), co-IP, localization, AlphaFold3 structural modeling, and developmental RNA-seq; this triangulation strengthens internal consistency (Preprint: multi-method approach).
2. Quantitative DNA-binding data with competition controls (WT vs mutant oligo) supporting sequence-specific binding rather than non-specific DNA association (Preprint: DNA-binding specificity).
3. Provision of RNA-seq accessions / resource pointers (MARIMBA) and code availability links for single-cell analyses (Zenodo/GitHub links referenced), increasing transparency for the expression analyses (Preprint: data & code availability).

Critical appraisal — limitations, blind spots, and places data could mislead

• Heterologous systems: Nearly all activity/localization/function assays were performed in vertebrate (HEK 293/293T or DF-1) cells or yeast. This is a major source of interpretive uncertainty because co-factors, post-translational modification enzymes, chromatin context, or accessory proteins needed for transcriptional activation in jellyfish may be absent. Therefore the negative HEK reporter result for Aa/Ch does not prove these proteins are inactive as transcriptional activators in native jellyfish cells (Preprint: heterologous assay limitation).
• mRNA→protein inference: The developmental expression interpretation assumes mRNA levels reflect protein abundance and activity; this is explicitly recognized by the authors as an assumption and could be false if translational control or protein stability differ across stages.
• Sample sizes & single-cell sensitivity: The single-cell signals for a transcription factor are noted as low; low UMI counts can lead to false negatives in cell-type assignment and under-represent expression in rare cells — the paper mentions low transcript levels for NF-κB in the single-cell atlas, so conclusions about cell-type specificity should be cautious (Preprint: single-cell detection limits).
• AlphaFold3 structural conclusions: AlphaFold3 docking is useful but not a substitute for experimental structural biology; the RMSD comparisons reported (jellyfish vs mouse p50) are informative but should not alone be used to infer functional equivalency of interaction interfaces or dynamics in native complexes.
• Evolutionary interpretation risks: The paper interprets structure/function differences as species-specific regulatory adaptation (development vs immune roles). While plausible, these inferences rest on mRNA patterns and heterologous functional assays; proving evolutionary function requires perturbation in the native organism (knockdown, CRISPR, rescue) and phenotypic readouts.
• Conflict of interest & funding bias: Funding is academic (NSF, BU, Freedom Together Foundation); no COI declared, but undergraduate-lab involvement and course-based research (BB522) are explicitly stated and may affect depth of some experiments (not a bias per se, but relevant for expected experimental scale).

How convincing are the main claims?

- Claim: Jellyfish NF-κB proteins specifically bind κB DNA sites — convincing within the assay context (strong, sequence-competition controls give confidence).
- Claim: These NF-κB proteins do not activate a κB-site reporter in HEK cells — valid for the heterologous HEK assay, but cannot be generalized to jellyfish biology (moderate, assay-limited).
- Claim: IκB-like proteins interact and regulate subcellular localization — supported by co-IP, localization shifts, and AlphaFold docking (moderate-to-strong within heterologous systems).
- Claim: NF-κB functions in early development in Clytia — plausible given mRNA patterns but currently inferential; requires in vivo perturbation for confirmation (weak-to-moderate).

Concrete, high-value follow-ups (experiments that would change conclusions)

1. CRISPR/Cas or morpholino knockdown of Ch-NF-κB in early Clytia embryos with scoring for developmental phenotypes (cnidocyte formation, gastrulation defects) and rescue with wild-type or DNA-binding mutant constructs — would directly test developmental role (falsifies/strengthens developmental claim).
2. Chromatin immunoprecipitation (ChIP) using an antibody against endogenous Ch-NF-κB (or epitope-tagged knock-in) in Clytia early-stage tissue to detect native genomic binding and identify target genes — would confirm in vivo DNA-binding targets and separate binding from activation capacity.
3. Proteomics to identify jellyfish-specific NF-κB co-factors or post-translational modifications (phosphorylation, ubiquitination) that enable transcriptional activation; test these in HEK reporter assays by co-expressing candidate co-factors to rescue activation.
4. Quantitative western blot or mass spec to compare NF-κB and IκB protein levels across developmental stages to validate the mRNA→protein assumption.

Paper scoring (critical, skeptical)

• paper_novelty: 7
• paper_novelty_explanation: Comparative functional data for two jellyfish species combining AlphaFold3, biochemical assays and stage-resolved expression is novel for scyphozoan/hydrozoan NF-κB and advances knowledge beyond single-species reports.
• paper_quality: 7
• paper_quality_explanation: Experiments are clear, controlled (competition assays, co-IPs, localization counts) and methods are described; major quality limits come from reliance on heterologous systems and limited in vivo perturbation to connect molecular facts to organismal function.
• paper_generality: 5
• paper_generality_explanation: Findings generalize to understanding NF-κB evolution but specific functional conclusions (development vs immunity) are species/context-dependent and thus only moderately general.
• paper_usefulness: 6
• paper_usefulness_explanation: Useful for researchers studying NF-κB evolution, cnidarian development and immunity; provides reagents, sequences and hypotheses for functional follow-up, but limited immediate translational or broad mechanistic utility without in vivo follow-up.
• paper_reproducibility: 7
• paper_reproducibility_explanation: Methods (plasmids, transfections, TransAM modification, RNA-seq sources) are described; code links for RNA analysis are provided. Reproducibility limited by availability of jellyfish colonies, codon-optimized constructs and potential variability in heterologous cell assays.
• explanatory_depth: 6
• explanatory_depth_explanation: Paper provides mechanistic clues (DNA binding, IκB interactions, structural docking) but stops short of in vivo mechanism or identification of native target genes and co-factors.

Key insight (concise)

Basal metazoan NF-κB proteins can retain conserved DNA-recognition geometry while evolving species-specific regulatory interfaces and co-factor dependencies that decouple DNA binding from transactivation in heterologous systems — implying that surveying only DNA-binding is insufficient to infer regulatory function across phyla (Preprint: conserved binding, divergent activation).

Novel, testable hypotheses

1. Ch-NF-κB is a developmentally active transcription factor whose target set in gastrula/planula includes cnidocyte-differentiation genes; loss-of-function will reduce cnidocyte numbers (testable by CRISPR/morpholino and cnidocyte markers).
2. Aa-NF-κB contains an intrinsic activation surface that functions in yeast but is inactive in vertebrate chromatin due to missing jellyfish-specific coactivator(s); co-expression of candidate jellyfish coactivators in HEK cells will restore κB-reporter activation.

Novel experiments (concise protocols)

1. In vivo Ch-NF-κB perturbation: Microinject Clytia zygotes with Cas9 RNPs targeting NF-κB or translation-blocking morpholino; assay gastrula/planula morphology, cnidocyte markers (staining), and perform RNA-seq on knocked-down embryos to identify direct/indirect targets; include rescue with Cas9-resistant tagged NF-κB to confirm specificity.
2. ChIP–seq in early-stage Clytia: Generate an epitope-tag knock-in (e.g., HA) at endogenous NF-κB; crosslink early gastrula tissue, immunoprecipitate HA, prepare libraries and sequence to identify genomic NF-κB binding sites and motif enrichment; integrate with RNA-seq to define regulated genes.

Short guidance for authors / how to improve the study

Add at least one native-organism perturbation (morpholino or CRISPR) or ChIP experiment; provide western/protein-level quantification across stages to validate mRNA inferences; attempt co-expression of candidate jellyfish co-factors in HEK or use jellyfish primary cells / explants to test activation directly.

Notes on evidence strength: conclusions about molecular interactions, DNA binding and localization are supported by direct biochemical and cell-based assays reported in the preprint; organismal/developmental claims are plausible but inferential and require perturbation experiments in the native animals for stronger support (Preprint: limitations acknowledged).